Company intelligence / Profile preview

R3 Vascular

Mountain View, California, United States

Ownership: Private
Development stage: Phase 3

Overview

R3 Vascular’s MAGNITUDE bioresorbable sirolimus-eluting scaffold has shown promising procedural results in first-in-human studies for critical limb ischemia due to below-the-knee arterial disease. The company has received IRB and CMS Category B approval for its pivotal ELITE-BTK trial in the US, with Medicare coverage for study-related costs. The device aims to provide stent-like support while gradually dissolving as the vessel heals, potentially improving long-term outcomes over metal stents or balloon angioplasty alone. Clinical development remains ongoing.

Therapeutic areas: Cardiovascular
Modalities: DevicePolymer-based drug delivery therapy (bioresorbable scaffold)Small molecule (sirolimus coating)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

MAGNITUDE

Phase 3

Indications: Peripheral arterial disease, Chronic limb-threatening ischemia

Partnerships

Registry partnerships such as RAPID for real-world evidence generation

Beyond the preview

Go deeper on R3 Vascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on R3 Vascular.

Explore the full profile